Platelet-rich plasma ameliorates cisplatin-induced premature ovarian insufficiency in rats by alleviating oxidative stress and granulosa cell apoptosis

Platelet-rich plasma protects HUVECs against oX-LDL-induced Injury

10.1515/med-2018-0007 · doi-reference

The Nrf2/HO-1 pathway participates in the antiapoptotic and anti-inflammatory effects of platelet-rich plasma in the treatment of osteoarthritis

10.1002/iid3.1169 · doi-reference

Activation of apoptosis signalling pathways by reactive oxygen species

10.1016/j.bbamcr.2016.09.012 · doi-reference

Mechanisms of BCL-2 family proteins in mitochondrial apoptosis

10.1038/s41580-023-00629-4 · doi-reference

Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage

10.1186/s12958-018-0404-4 · doi-reference

Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD

10.1186/s13287-018-0953-7 · doi-reference

Follicular growth and atresia in mammalian ovaries: regulation by survival and death of granulosa cells

10.1262/jrd.2011-012 · doi-reference

Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants

10.3389/fendo.2023.1172481 · doi-reference

A retrospective cohort study investigating the effect of intraovarian platelet-rich plasma therapy on the oxidative state of follicular fluid in women with diminished ovarian reserve

10.4068/cmj.2025.61.1.46 · doi-reference

The effects of oxidative stress on female reproduction: a review

10.1186/1477-7827-10-49 · doi-reference

The protective effect of co-administration of platelet-rich plasma (PRP) and pentoxifylline (PTX) on cyclophosphamide-induced premature ovarian failure in mature and immature rats

10.1080/15376516.2022.2057264 · doi-reference

How do chemotherapeutic agents damage the ovary?

10.1093/humupd/dms022 · doi-reference

Mechanism of platelet-rich plasma in improving cyclophosphamide-induced premature ovarian failure in rats

10.1186/s13287-025-04779-4 · doi-reference

The mammalian ovary from genesis to revelation

10.1210/er.2009-0012 · doi-reference

ESHRE Guideline: management of women with premature ovarian insufficiency

10.1093/humrep/dew027 · doi-reference

Anti-Müllerian hormone: a new marker for ovarian function

10.1530/rep.1.00529 · doi-reference

The antibody registry: ten years of registering antibodies

10.1093/nar/gkac927 · doi-reference

Morphometric analysis of follicular development in the rat

10.1095/biolreprod19.3.597 · doi-reference

Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears

10.1177/0192623315570339 · doi-reference

Platelet-rich plasma protects human keratinocytes from UVB-induced apoptosis by attenuating inflammatory responses and endoplasmic reticulum stress

10.1111/jocd.15559 · doi-reference

Platelets rich plasma increases antioxidant defenses of tenocytes via Nrf2 signal pathway

10.3390/ijms241713299 · doi-reference

Pretreatment with platelet-rich plasma protects against ischemia-reperfusion induced flap injury by deactivating the JAK/STAT pathway in mice

10.1186/s10020-024-00781-3 · doi-reference

Platelet-Rich Plasma (PRP) in reproductive medicine: a critical review of PRP therapy in low-reserve and premature ovarian insufficiency

10.3390/biomedicines13051257 · doi-reference

Protective effects of platelet-rich plasma for in vitro fertilization of rats with ovarian failure induced by Cyclophosphamide

10.1055/s-0041-1741451 · doi-reference

Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation

10.1186/s12958-020-00638-4 · doi-reference

Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency

10.18632/aging.103403 · doi-reference

Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP)

10.18632/aging.203972 · doi-reference

The regenerative mechanisms of platelet-rich plasma: a review

10.1016/j.cyto.2021.155560 · doi-reference

Biotherapeutic applications of platelet-rich plasma in regenerative medicine

10.1007/s13770-023-00560-x · doi-reference

A review of platelet-rich plasma: history, biology, mechanism of action, and classification

10.1159/000477353 · doi-reference

Platelet-rich plasma: underlying biology and clinical correlates

10.2217/rme.13.59 · doi-reference

Oxidative stress-induced apoptosis in granulosa cells involves JNK, p53 and Puma

10.18632/oncotarget.15813 · doi-reference

An overview of different methods to establish a murine premature ovarian failure model

10.1002/ame2.12477 · doi-reference

Chemotherapy induced oxidative stress in the ovary: drug-dependent mechanisms and potential interventions

10.1093/biolre/ioac222 · doi-reference

Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin

10.1038/s41598-023-31712-7 · doi-reference

Research progress on the premature ovarian failure caused by cisplatin therapy

10.3389/fonc.2023.1276310 · doi-reference

Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage

10.1093/humupd/dmae020 · doi-reference

HRT for women with premature ovarian insufficiency: a comprehensive review

10.1093/hropen/hox007 · doi-reference

Therapeutic options for premature ovarian insufficiency: an updated review

10.1186/s12958-022-00892-8 · doi-reference

Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study

10.1186/s12978-022-01559-8 · doi-reference